@article{510f3c78159b47e4be37c1c884eeffdb,
title = "Ibrutinib and Venetoclax for First-Line Treatment of CLL",
keywords = "Bridged Bicyclo Compounds, Heterocyclic, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Pyrazoles, Pyrimidines, Sulfonamides",
author = "Kater, \{Arnon P\} and Mark-David Levin and Niemann, \{Carsten U\}",
year = "2019",
month = aug,
day = "22",
doi = "10.1056/NEJMc1908754",
language = "English",
volume = "381",
pages = "788--789",
journal = "The New England journal of medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "8",
}